https://andards.com/categories/longevity-biotech-and-ai/ Recent content in Longevity Biotech and AI on AndArds Hugo -- gohugo.io en-us Sun, 05 Apr 2026 04:06:00 +0000 https://andards.com/posts/deep-aging-clocks-how-ai-is-finding-new-ways-to-measure-biological-age/ Sun, 05 Apr 2026 04:06:00 +0000 https://andards.com/posts/deep-aging-clocks-how-ai-is-finding-new-ways-to-measure-biological-age/ Our chronological age, the number of years since birth, is a straightforward metric. However, it often doesn’t tell the full story of our health or how our bodies are actually aging. Biological age, on the other hand, reflects the physiological state of our cells and tissues, which can diverge significantly from our chronological age. https://andards.com/posts/ai-and-gene-editing-the-next-decade-of-longevity-biotech/ Sun, 05 Apr 2026 00:33:00 +0000 https://andards.com/posts/ai-and-gene-editing-the-next-decade-of-longevity-biotech/ The quest to extend healthy human lifespan is undergoing a transformation, propelled by the convergence of artificial intelligence (AI) and gene editing technologies. Over the next decade, these fields are poised to redefine what’s possible in longevity biotech, moving beyond theoretical discussions to tangible, therapeutic interventions. https://andards.com/posts/longevity-escape-velocity-lev-aubrey-de-greys-timeline-explained/ Sat, 04 Apr 2026 04:34:00 +0000 https://andards.com/posts/longevity-escape-velocity-lev-aubrey-de-greys-timeline-explained/ Longevity Escape Velocity (LEV) refers to a hypothetical point in the future when medical advancements allow humans to extend their lives by more than one year for every year that passes. In simpler terms, for each year you live, science would add more than a year to your remaining life expectancy. https://andards.com/posts/laura-demings-longevity-fund-the-startups-trying-to-cure-aging/ Sun, 29 Mar 2026 02:01:00 +0000 https://andards.com/posts/laura-demings-longevity-fund-the-startups-trying-to-cure-aging/ The idea of “curing aging” might sound like science fiction, but a growing number of scientists, entrepreneurs, and investors are dedicating significant resources to making it a reality. At the forefront of this effort is Laura Deming, whose Longevity Fund has become a pivotal force in identifying and backing early-stage companies focused on extending healthy human lifespan. https://andards.com/posts/the-fda-and-aging-why-we-need-to-classify-aging-as-a-disease/ Wed, 25 Mar 2026 04:49:00 +0000 https://andards.com/posts/the-fda-and-aging-why-we-need-to-classify-aging-as-a-disease/ The idea of classifying aging as a disease might seem counter-intuitive at first glance. After all, aging is a universal human experience, not typically viewed through the same lens as cancer or diabetes. However, a growing number of scientists, clinicians, and policymakers argue that formally recognizing aging as a disease by regulatory bodies like the U. https://andards.com/posts/the-ethics-of-extreme-longevity-who-gets-to-live-to-150/ Sun, 22 Mar 2026 02:53:00 +0000 https://andards.com/posts/the-ethics-of-extreme-longevity-who-gets-to-live-to-150/ The prospect of living significantly longer than the current human lifespan, perhaps to 150 years or beyond, is shifting from science fiction to a plausible future. Advances in biogerontology, genetics, and regenerative medicine suggest that extreme longevity might one day be achievable. https://andards.com/posts/sergey-youngs-vision-for-200-year-lifespans-is-it-realistic/ Sun, 01 Mar 2026 01:22:00 +0000 https://andards.com/posts/sergey-youngs-vision-for-200-year-lifespans-is-it-realistic/ Sergey Young, a venture capitalist and longevity advocate, frequently articulates a vision of human lifespans extending to 200 years. This isn’t a casual musing but a central tenet of his work, particularly through his Longevity Vision Fund and his book, “Growing Young. https://andards.com/posts/alex-zhavoronkov-and-insilico-medicine-ais-role-in-curing-aging/ Sun, 22 Feb 2026 18:53:00 +0000 https://andards.com/posts/alex-zhavoronkov-and-insilico-medicine-ais-role-in-curing-aging/ Alex Zhavoronkov and Insilico Medicine are at the forefront of a movement aiming to revolutionize drug discovery and extend healthy human lifespan using artificial intelligence. Their work centers on the idea that aging is a treatable disease, and that AI can dramatically accelerate the process of identifying and developing therapies to address it. https://andards.com/posts/sebastian-brunemeier-and-the-rise-of-longevity-venture-capital/ Wed, 18 Feb 2026 00:46:00 +0000 https://andards.com/posts/sebastian-brunemeier-and-the-rise-of-longevity-venture-capital/ Sebastian Brunemeier is a figure at the intersection of biotechnology and finance, known for his work in the longevity venture capital space. His involvement with entities like Healthspan Capital and LongGame Ventures highlights a growing trend: the focused investment in companies aiming to extend human healthspan, not just lifespan. https://andards.com/posts/george-churchs-crispr-therapies-are-we-ready-for-human-trials/ Thu, 08 Jan 2026 21:25:00 +0000 https://andards.com/posts/george-churchs-crispr-therapies-are-we-ready-for-human-trials/ The prospect of using CRISPR gene editing to slow, stop, or even reverse aspects of aging is a recurring theme in conversations about longevity. At the forefront of this discussion is George Church, a pioneering geneticist at Harvard Medical School.